Skip to main content
. 2021 Aug 20;11(8):e049384. doi: 10.1136/bmjopen-2021-049384

Table 1.

Details of clinical variables of the study participants

Characteristic Mean (SD)
Preintervention tinnitus severity (measured using TFI, scores range 0–11) 57.93 (19.17)
Postintervention tinnitus severity (measured using TFI, scores range 0–11) 34.22 (22.76)
2-month follow-up tinnitus severity (measured using TFI, scores range 0–11) 34.23 (24.19)
Anxiety (measured using GAD-7, scores range 0–21) 7.29 (5.52)
Depression (measured using PHQ-9, scores range 0–27) 7.61 (5.73)
Insomnia (measured using ISI, scores range 0–28) 12.49 (6.67)
Hyperacusis (measured using HQ, scores range 0–40) 18.33 (9.05)
Hearing disability (measured using the HHIA-S, scores range 0–40) 16.18 (11.64)
Cognitive failures (measured using the CFQ, scores range 0–100) 38.54 (15.63)
Life satisfaction (measured using SWLS, scores range 0–40) 20.71 (7.55)

CFQ, Cognitive Failures Questionnaire; GAD-7, generalised anxiety disorder; HHIA-S, Hearing Handicap Inventory for Adults Screening; HQ, Hyperacusis Questionnaire; ISI, Insomnia Severity Index; PHQ-9, Patient Health Questionnaire; SWLS, Satisfaction with Life Scales; TFI, Tinnitus Functional Index.